This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
An international workshop entitled ``Research Priorities for Syringomyelia,'' sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health (NIH), was held in Chantilly, Virginia, June 20 and 21, 1994. This workshop brought together a group of basic and clinical investigators to discuss the current clinical understanding and management of syringomyelia, recent technical advances, and future research priorities. Ann Charnley, representing the American Syringomyelia Alliance Project, and Richard Grant, from the Paralyzed Veterans of American, made presentations in which they discussed patient perspectives on syringomyelia.
The workshop focused on the following topics: pathology, CSF dynamics and pathophysiology, and clinical management of congenital and acquired syringomyelia. Panel discussions followed each topic, and priorities for future research objectives were formulated at the final session.
Background.
Syringomyelia is a disorder characterized by an abnormal fluid-filled cyst (syrinx) in the spinal cord, which causes progressive neurologic symptoms as it expands Syringomyelia may be congenital or acquired. It most commonly occurs in the cervical segments of the spinal cord but can involve the entire length of the spinal cord and occasionally extends into the brainstem (syringobulbia). Most cases considered to be congenital present in adulthood and are associated with hindbrain herniation (Chiari type I). Infantile forms are associated with the more severe Chiari types II and III abnormalities.
Posttraumatic spinal cord cavitation is a progressive disorder in which initial spinal cord damage leads to altered CSF hydrodynamics and arachnoiditis, resulting in progressive expansion and extension of the syrinx. Syringomyelia may also occur after intradural spinal surgery, such as resection of a spinal cord tumor. Postinflammatory syringomyelia, which may result from infections (e.g., tubercular, fungal, parasitic) or from chemical meningitis, is commonly associated with arachnoidal scarring.
To understand the underlying causes of syringomyelia, it is necessary to understand the structure and …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard